- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Beryl Drugs Limited shareholders have approved the re-appointment of Mr. Sanjay Sethi (DIN: 00090277) as the company's Managing Director for a five-year term, effective from 11th December, 2025. Mr. Sethi, 62, brings 43 years of experience and a B. Pharma qualification to the role. This decision ensures leadership continuity for the company's strategic direction and operational stability. He is related to another director and is not debarred from holding office by any regulatory authority.